- Home
- Publications
- Publication Search
- Publication Details
Title
A New Paradigm for Achieving a Rapid Antidepressant Response
Authors
Keywords
-
Journal
DRUGS
Volume 80, Issue 8, Pages 755-764
Publisher
Springer Science and Business Media LLC
Online
2020-04-28
DOI
10.1007/s40265-020-01303-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Psychotropic polypharmacy reconsidered: Between-class polypharmacy in the context of multimorbidity in the treatment of depressive disorders
- (2019) Taeho Greg Rhee et al. JOURNAL OF AFFECTIVE DISORDERS
- Brexpiprazole for treatment-resistant major depressive disorder
- (2019) Michele Fornaro et al. EXPERT OPINION ON PHARMACOTHERAPY
- Efficacy and safety of adjunctive therapy using esketamine or racemic ketamine for adult treatment-resistant depression: A randomized, double-blind, non-inferiority study
- (2019) Fernanda S. Correia-Melo et al. JOURNAL OF AFFECTIVE DISORDERS
- Make News: Treatment-Resistant Depression – an irreversible problem in need of a reversible solution?
- (2019) Gin S Malhi et al. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
- Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide: Results of a Double-Blind, Randomized, Placebo-Controlled Study
- (2018) Carla M. Canuso et al. AMERICAN JOURNAL OF PSYCHIATRY
- Antidepressant Efficacy and Tolerability of Ketamine and Esketamine: A Critical Review
- (2018) P. Molero et al. CNS DRUGS
- Antipsychotic Prescriptions Among Adults With Major Depressive Disorder in Office-Based Outpatient Settings
- (2018) Taeho Greg Rhee et al. JOURNAL OF CLINICAL PSYCHIATRY
- Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression
- (2018) Ella J. Daly et al. JAMA Psychiatry
- Management of common adverse effects of antipsychotic medications
- (2018) T. Scott Stroup et al. World Psychiatry
- Prevalence of Depression in the Community from 30 Countries between 1994 and 2014
- (2018) Grace Y. Lim et al. Scientific Reports
- Treatment-resistant depression: problematic illness or a problem in our approach?
- (2018) Gin S. Malhi et al. BRITISH JOURNAL OF PSYCHIATRY
- Rapid-Acting Antidepressants
- (2018) Jeffrey M. Witkin et al. CURRENT PHARMACEUTICAL DESIGN
- Depression
- (2018) Gin S Malhi et al. LANCET
- New targets for rapid antidepressant action
- (2017) Rodrigo Machado-Vieira et al. PROGRESS IN NEUROBIOLOGY
- Intravenous Esketamine in Adult Treatment-Resistant Depression: A Double-Blind, Double-Randomization, Placebo-Controlled Study
- (2016) Jaskaran B. Singh et al. BIOLOGICAL PSYCHIATRY
- Adjunctive Brexpiprazole: A Review in Major Depressive Disorder
- (2016) Kate McKeage CNS DRUGS
- Screen all for depression
- (2016) Mark Sinyor et al. BMJ-British Medical Journal
- Screen all for depression
- (2016) Mark Sinyor et al. BMJ-British Medical Journal
- Major depressive disorder
- (2016) Christian Otte et al. Nature Reviews Disease Primers
- Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders
- (2015) Gin S Malhi et al. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
- Atypical Antipsychotic Augmentation for Treatment-Resistant Depression: A Systematic Review and Network Meta-Analysis
- (2015) Xinyu Zhou et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Adjunctive Brexpiprazole 1 and 3 mg for Patients With Major Depressive Disorder Following Inadequate Response to Antidepressants
- (2015) Michael E. Thase et al. JOURNAL OF CLINICAL PSYCHIATRY
- Efficacy and Safety of Adjunctive Brexpiprazole 2 mg in Major Depressive Disorder
- (2015) Michael E. Thase et al. JOURNAL OF CLINICAL PSYCHIATRY
- What Did STAR*D Teach Us? Results From a Large-Scale, Practical, Clinical Trial for Patients With Depression
- (2014) Bradley N. Gaynes et al. PSYCHIATRIC SERVICES
- Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis
- (2013) A. Cipriani et al. BMJ-British Medical Journal
- Adjunctive Atypical Antipsychotic Treatment for Major Depressive Disorder: A Meta-Analysis of Depression, Quality of Life, and Safety Outcomes
- (2013) Glen I. Spielmans et al. PLOS MEDICINE
- Sub-anesthetic concentrations of (R,S)-ketamine metabolites inhibit acetylcholine-evoked currents in α7 nicotinic acetylcholine receptors
- (2012) Ruin Moaddel et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Lithium toxicity profile: a systematic review and meta-analysis
- (2012) Rebecca F McKnight et al. LANCET
- Intravenous Ketamine for Treatment-Resistant Major Depressive Disorder
- (2011) Jordan R Covvey et al. ANNALS OF PHARMACOTHERAPY
- National Trends in Psychotropic Medication Polypharmacy in Office-Based Psychiatry
- (2010) Ramin Mojtabai et al. ARCHIVES OF GENERAL PSYCHIATRY
- The increased use of antidepressants has contributed to the worldwide reduction in suicide rates
- (2010) Göran Isacsson et al. BRITISH JOURNAL OF PSYCHIATRY
- Olanzapine/Fluoxetine
- (2010) Jamie D. Croxtall et al. CNS DRUGS
- Aripiprazole as Adjunctive Therapy for Patients with Major Depressive Disorder
- (2010) Chi-Un Pae et al. CNS DRUGS
- Patterns in the use of benzodiazepines in British Columbia: Examining the impact of increasing research and guideline cautions against long-term use
- (2010) Colleen M. Cunningham et al. HEALTH POLICY
- Quetiapine XR: Current status for the treatment of major depressive disorder
- (2010) Chi-Un Pae et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Atypical Antipsychotic Augmentation in Major Depressive Disorder: A Meta-Analysis of Placebo-Controlled Randomized Trials
- (2009) J. Craig Nelson et al. AMERICAN JOURNAL OF PSYCHIATRY
- Predictors of the incidence and discontinuation of long-term use of benzodiazepines: A population-based study
- (2009) Shao-You Fang et al. DRUG AND ALCOHOL DEPENDENCE
- Augmentation of antidepressants with atypical antipsychotics for treatment-resistant major depressive disorder
- (2008) Richard C. Shelton et al. ACTA PSYCHIATRICA SCANDINAVICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started